drugset / Trial / NCT01238185
Aspirin Mouthwash in Treating Patients With Oral Leukoplakia
Open-labelTreatment
Summary
RATIONALE: Aspirin mouthwash may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase I trial is studying the side effects and best dose of aspirin mouthwash in treating patients with oral leukoplakia.
Timeline
- Start
- 2010-02
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 75 mg | Topical |
| Subject | Aspirin | Small molecule | 150 mg | Topical |
| Subject | Aspirin | Small molecule | 300 mg | Topical |